Preliminary safety assessment of oridonin in zebrafish

References

• Antonuzzo L, Lunghi A, Petreni P, Brugia M, Laffi A, Giommoni E, Mela MM, Mazzoni F, Balestri V, Costanzo FD. 2017. Osteonecrosis of the jaw and angiogenesis inhibitors: a revival of a rare but serous side effect. Curr Med Chem. 24(28):3068–3076.
   PubMed Web of Science ®Google Scholar
• Baeyens N, Nicoli S, Coon BG, Ross TD, Van den Dries K, Han J, Lauridsen HM, Mejean CO, Eichmann A, Thomas JL, et al. 2015. Vascular remodeling is governed by a VEGFR3-dependent fluid shear stress set point. Elife. 4:e04645.
   Web of Science ®Google Scholar
• Bakkers J. 2011. Zebrafish as a model to study cardiac development and human cardiac disease. Cardiovasc Res. 91(2):279–288.
   PubMed Web of Science ®Google Scholar
• Cao S, Xia M, Mao Y, Zhang Q, Donkor PO, Qiu F, Kang N. 2016. Combined oridonin with cetuximab treatment shows synergistic anticancer effects on laryngeal squamous cell carcinoma: involvement of inhibition of EGFR and activation of reactive oxygen species-mediated JNK pathway. Int J Oncol. 49(5):2075–2087.
   PubMed Web of Science ®Google Scholar
• Carmeliet P, Jain RK. 2011. Molecular mechanisms and clinical applications of angiogenesis. Nature. 473(7347):298–307.
   PubMed Web of Science ®Google Scholar
• Chen J, Saili KS, Liu Y, Li L, Zhao Y, Jia Y, Bai C, Tanguay RL, Dong Q, Huang C. 2017. Developmental bisphenol A exposure impairs sperm function and reproduction in zebrafish. Chemosphere. 169:262–270.
   PubMed Web of Science ®Google Scholar
• Chen SS, Michael A, Butler-Manuel SA. 2012. Advances in the treatment of ovarian cancer: a potential role of antiinflammatory phytochemicals. Discov Med. 13(68):7–17.
   PubMed Web of Science ®Google Scholar
• Choi HS, Kim MK, Lee K, Lee KM, Choi YK, Shin YC, Cho SG, Ko S. 2016. SH003 represses tumor angiogenesis by blocking VEGF binding to VEGFR2. Oncotarget. 7(22):32969–32979.
   PubMedGoogle Scholar
• Cornet C, Calzolari S, Miñana-Prieto R, Dyballa S, van Doornmalen E, Rutjes H, Savy T, D’Amico D, Terriente J. 2017. ZeGlobalTox: an innovative approach to address organ drug toxicity using zebrafish. IJMS. 18(4):864.
   Web of Science ®Google Scholar
• Dao TT, Le TV, Nguyen PH, Thuong PT, Minh PT, Woo ER, Lee KY, Oh WK. 2010. SIRT1 inhibitory diterpenoids from the Vietnamese medicinal plant Croton tonkinensis. Planta Med. 76(10):1011–1014.
   PubMed Web of Science ®Google Scholar
• Ding C, Zhang Y, Chen H, Yang Z, Wild C, Ye N, Ester CD, Xiong A, White MA, Shen Q, et al. 2013. Oridonin ring A-based diverse constructions of enone functionality: identification of novel dienone analogues effective for highly aggressive breast cancer by inducing apoptosis. J Med Chem. 56(21):8814–8825.
   PubMed Web of Science ®Google Scholar
• Dong Y, Zhang T, Li J, Deng H, Song Y, Zhai D, Peng Y, Lu X, Liu M, Zhao Y, et al. 2014. Oridonin inhibits tumor growth and metastasis through anti-angiogenesis by blocking the Notch signaling. PLoS One. 9(12):e113830.
   PubMed Web of Science ®Google Scholar
• Ferrara N, Gerber H-P, LeCouter J. 2003. The biology of VEGF and its receptors. Nat Med. 9(6):669–676.
   PubMed Web of Science ®Google Scholar
• Field HA, Dong PD, Beis D, Stainier DY. 2003. Formation of the digestive system in zebrafish. II. Pancreas morphogenesis. Dev Biol. 261(1):197–208.
   PubMed Web of Science ®Google Scholar
• Frandsen S, Kopp S, Wehland M, Pietsch J, Infanger M, Grimm D. 2016. Latest results for anti-angiogenic drugs in cancer treatment. Curr Pharm Des. 22(39):5927–5942.
   PubMed Web of Science ®Google Scholar
• Fraysse B, Mons R, Garric J. 2006. Development of a zebrafish 4-day embryo-larval bioassay to assess toxicity of chemicals. Ecotoxicol Environ Saf. 63(2):253–267.
   PubMed Web of Science ®Google Scholar
• Gao F, Tang Q, Yang P, Fang Y, Li W, Wu Y. 2010. Apoptosis inducing and differentiation enhancement effect of oridonin on the all-trans-retinoic acid-sensitive and -resistant acute promyelocytic leukemia cells. Int J Lab Hematol. 32(1 Pt 1):e114–122.
   PubMed Web of Science ®Google Scholar
• Jing RY, Huang CJ, Bai CL, Tanguay R, Dong QX. 2009. Optimization of activation, collection, dilution, and storage methods for zebrafish sperm. Aquaculture. 290(1–2):165–171.
   Web of Science ®Google Scholar
• Kadioglu O, Saeed M, Kuete V, Greten HJ, Efferth T. 2018. Oridonin targets multiple drug-resistant tumor cells as determined by in silico and in vitro analyses. Front Pharmacol. 9:355.
   PubMed Web of Science ®Google Scholar
• Kang N, Zhang JH, Qiu F, Chen S, Tashiro S, Onodera S, Ikejima T. 2010a. Induction of G(2)/M phase arrest and apoptosis by oridonin in human laryngeal carcinoma cells. J Nat Prod. 73(6):1058–1063.
   PubMed Web of Science ®Google Scholar
• Kang N, Zhang JH, Qiu F, Tashiro S, Onodera S, Ikejima T. 2010b. Inhibition of EGFR signaling augments oridonin-induced apoptosis in human laryngeal cancer cells via enhancing oxidative stress coincident with activation of both the intrinsic and extrinsic apoptotic pathways. Cancer Lett. 294(2):147–158.
   PubMed Web of Science ®Google Scholar
• Kimmel CB, Ballard WW, Kimmel SR, Ullmann B, Schilling TF. 1995. Stages of embryonic development of the zebrafish. Dev Dyn. 203(3):253–310.
   PubMed Web of Science ®Google Scholar
• Kulkarni P, Medishetti R, Nune N, Yellanki S, Sripuram V, Rao P, Sriram D, Saxena U, Oruganti S, et al. 2017. Correlation of pharmacokinetics and brain penetration data of adult zebrafish with higher mammals including humans. J Pharmacol Toxicol Methods. 88(Pt 2):147–152.
   PubMed Web of Science ®Google Scholar
• Kumar M, Dhatwalia SK, Dhawan DK. 2016. Role of angiogenic factors of herbal origin in regulation of molecular pathways that control tumor angiogenesis. Tumour Biol. 37(11):14341–14354.
   PubMedGoogle Scholar
• Liu H, Qian C, Shen Z. 2014. Anti-tumor activity of oridonin on SNU-5 subcutaneous xenograft model via regulation of c-Met pathway. Tumour Biol. 35(9):9139–9146.
   PubMedGoogle Scholar
• Liu J, Yang F, Zhang Y, Li J. 2007. Studies on the cell-immunosuppressive mechanism of oridonin from Isodon serra. Int Immunopharmacol. 7(7):945–954.
   PubMed Web of Science ®Google Scholar
• Liu QQ, Chen K, Ye Q, Jiang XH, Sun YW. 2016. Oridonin inhibits pancreatic cancer cell migration and epithelial-mesenchymal transition by suppressing Wnt/β-catenin signaling pathway. Cancer Cell Int. 16:57.
   PubMed Web of Science ®Google Scholar
• Lu K, Bhat M, Basu S. 2016. Plants and their active compounds: natural molecules to target angiogenesis. Angiogenesis. 19(3):287–295.
   PubMed Web of Science ®Google Scholar
• Meade-Tollin LC, Wijeratne EM, Cooper D, Guild M, Jon E, Fritz A, Zhou GX, Whitesell L, Liang JY, Gunatilaka AA. 2004. Ponicidin and oridonin are responsible for the antiangiogenic activity of Rabdosia rubescens, a constituent of the herbal supplement PC SPES. J Nat Prod. 67(1):2–4.
   PubMed Web of Science ®Google Scholar
• Mickoleit M, Schmid B, Weber M, Fahrbach FO, Hombach S, Reischauer S, Huisken J. 2014. High-resolution reconstruction of the beating zebrafish heart. Nat Methods. 11(9):919–922.
   PubMed Web of Science ®Google Scholar
• Park MN, Song HS, Kim M, Lee MJ, Cho W, Lee HJ, Hwang CH, Kim S, Hwang Y, Kang B, et al. 2017. Review of natural product-derived compounds as potent antiglioblastoma drugs. Biomed Res Int. 2017:8139848.
   PubMed Web of Science ®Google Scholar
• Parng C, Roy NM, Ton C, Lin Y, McGrath P. 2007. Neurotoxicity assessment using zebrafish. J Pharmacol Toxicol Methods. 55(1):103–112.
   PubMedGoogle Scholar
• Pi J, Jiang J, Cai H, Yang F, Jin H, Yang P, Cai J, Chen ZW. 2017. GE11 peptide conjugated selenium nanoparticles for EGFR targeted oridonin delivery to achieve enhanced anticancer efficacy by inhibiting EGFR-mediated PI3K/AKT and Ras/Raf/MEK/ERK pathways. Drug Deliv. 24(1):1549–1564.
   PubMed Web of Science ®Google Scholar
• Randrup Hansen C, Grimm D, Bauer J, Wehland M, Magnusson NE. 2017. Effects and side effects of using sorafenib and sunitinib in the treatment of metastatic renal cell carcinoma. IJMS. 18(2):461.
   Web of Science ®Google Scholar
• Rousseau S, Houle F, Huot J. 2000. Integrating the VEGF signals leading to actin-based motility in vascular endothelial cells. Trends Cardiovasc Med. 10(8):321–327.
   PubMed Web of Science ®Google Scholar
• Saint-Amant L, Drapeau P. 1998. Time course of the development of motor behaviors in the zebrafish embryo. J Neurobiol. 37(4):622–632.
   PubMedGoogle Scholar
• Shibuya M. 2011. Vascular endothelial growth factor (VEGF) and its receptor (VEGFR) signaling in angiogenesis: a crucial target for anti- and pro-angiogenic therapies. Genes Cancer. 2(12):1097–1105.
   PubMedGoogle Scholar
• Siveen KS, Prabhu K, Krishnankutty R, Kuttikrishnan S, Tsakou M, Alali FQ, Dermime S, Mohammad RM, Uddin S. 2017. Vascular endothelial growth factor (VEGF) signaling in tumour vascularization: potential and challenges. Curr Vasc Pharmacol. 15(4):339–351.
   PubMed Web of Science ®Google Scholar
• Spooner BS, Wessells NK. 1970. Mammalian lung development: interactions in primordium formation and bronchial morphogenesis. J Exp Zool. 175(4):445–454.
   PubMedGoogle Scholar
• Tian L, Xie K, Sheng D, Wan X, Zhu G. 2017. Antiangiogenic effects of oridonin. BMC Complement Altern Med. 17(1):192.
   PubMed Web of Science ®Google Scholar
• Truong L, Tanguay RL. 2017. Evaluation of embryotoxicity using the zebrafish model. Methods Mol Biol. 1641:325–333.
   PubMedGoogle Scholar
• Tsang B, Zahid H, Ansari R, Lee RC, Partap A, Gerlai R. 2017. Breeding zebrafish: a review of different methods and a discussion on standardization. Zebrafish. 14(6):561–573.
   PubMed Web of Science ®Google Scholar
• Wang S, Yang H, Yu L, Jin J, Qian L, Zhao H, Xu Y, Zhu X. 2014. Oridonin attenuates Aβ1-42-induced neuroinflammation and inhibits NF-κB pathway. PLoS One. 9(8):e104745.
   PubMed Web of Science ®Google Scholar
• Wang S, Yu L, Yang H, Li C, Hui Z, Xu Y, Zhu X. 2016. Oridonin attenuates synaptic loss and cognitive deficits in an Aβ1-42-Induced mouse model of Alzheimer's disease. PLoS One. 11(3):e0151397.
   PubMed Web of Science ®Google Scholar
• Westerfield M. 2000. The zebrafish book: A guide for the laboratory use of zebrafish (Danio rerio). 4th ed. Eugene (OR): University of Oregon.
   Google Scholar
• Xia S, Zhang X, Li C, Guan H. 2017. Oridonin inhibits breast cancer growth and metastasis through blocking the Notch signaling. Saudi Pharm J. 25(4):638–643.
   PubMed Web of Science ®Google Scholar
• Xu Y, Xue Y, Wang Y, Feng D, Lin S, Xu L. 2009. Multiple-modulation effects of oridonin on the production of proinflammatory cytokines and neurotrophic factors in LPS-activated microglia. Int Immunopharmacol. 9(3):360–365.
   PubMed Web of Science ®Google Scholar
• Yoo KY, Park SY. 2012. Terpenoids as potential anti-Alzheimer’s disease therapeutics. Molecules. 17(3):3524–3538.
   PubMed Web of Science ®Google Scholar
• Zhang F, Qin W, Zhang JP, Hu CQ. 2015. Antibiotic toxicity and absorption in zebrafish using liquid chromatography-tandem mass spectrometry. PLoS One. 10(5):e0124805.
   PubMed Web of Science ®Google Scholar
• Zhang ZY, Daniels R, Schluesener HJ. 2013. Oridonin ameliorates neuropathological changes and behavioural deficits in a mouse model of cerebral amyloidosis. J Cell Mol Med. 17(12):1566–1576.
   PubMed Web of Science ®Google Scholar
• Zhou GB, Kang H, Wang L, Gao L, Liu P, Xie J, Zhang FX, Weng XQ, Shen ZX, Chen J, et al. 2007. Oridonin, a diterpenoid extracted from medicinal herbs, targets AML1-ETO fusion protein and shows potent antitumor activity with low adverse effects on t(8;21) leukemia in vitro and in vivo. Blood. 109(8):3441–3450.
   PubMed Web of Science ®Google Scholar
• Zhu D, Fang Y, Gao K, Shen J, Zhong TP, Li F. 2017. VEGFA impacts early myocardium development in zebrafish. IJMS. 18(2):444.
   Web of Science ®Google Scholar
• Zuo PY, Chen XL, Liu YW, Xiao CL, Liu CY. 2014. Increased risk of cerebrovascular events in patients with cancer treated with bevacizumab: a meta-analysis. PLoS One. 9(7):e102484.
   PubMed Web of Science ®Google Scholar